NCT05297994 Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA Status COMPLETED Phase PHASE2
NCT05291676 Systems Investigation of Vaccine Responses in Aging and Frailty Status RECRUITING Phase PHASE2
NCT05290792 Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections Status COMPLETED Phase NA
NCT05284799 Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers. Status COMPLETED Phase PHASE2
NCT05277298 Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa Status UNKNOWN Phase N/A
NCT05252338 A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults Status COMPLETED Phase PHASE1
NCT05239403 Association Between Gut Microbiome and Dietary Determinants and Vaccine Response Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05215327 High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients Status RECRUITING Phase PHASE2
NCT05212623 A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months Status COMPLETED Phase PHASE1
NCT05190432 Taxifolin/Ergothioneine and Immune Biomarkers in Healthy Volunteers (TaxEr) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05184387 A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness. Status COMPLETED Phase N/A
NCT05170009 Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza Status TERMINATED Phase PHASE2/PHASE3
NCT05160636 A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05152017 The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05144464 A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years Status UNKNOWN Phase PHASE4
NCT05126979 The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years Status COMPLETED Phase PHASE1
NCT05095545 Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza Status COMPLETED Phase PHASE2
NCT05093998 Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza Status UNKNOWN Phase PHASE3